Eric Sullivan

Non-Executive Director / Chimeric Therapeutics

Mr Sullivan is a senior finance and operations leader in private-to-public biotechnology company building, strategy, fundraising and financial planning. He brings with him an background in the biotechnology sector, having served in senior finance and operations leadership roles across a number of high-growth public biotech companies, including bluebird bio, Merrimack Pharmaceuticals and TCR2 Therapeutics. Additionally, his experience with blue-chip private companies, such as Oncorus, Gemini Therapeutics, and Triplet Therapeutics.

Lists and Charts

Roles

2023

Non-Executive Director

Chimeric Therapeutics

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
1707^th	Iris Metals	-69.62%	0%
1708^th	Eagle Mountain Mining	-69.82%	-38.59%
1709^th	Chimeric Therapeutics	-69.89%	0%
1710^th	Zimi	-70%	24.57%
1711^th	Adavale Resources	-70%	-12.94%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Person Activity

NEW ROLE: Non-Executive Director, Chimeric Therapeutics

17 Jul 2024

Related Information

Access to our data for Eric Sullivan is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Eric Sullivan is linked to 3 organisations which are included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.